No Data
ATTENTION! The A-share ban will be lifted next Monday to exceed 40 billion yuan, and a large percentage of the unbanned stocks will be released
① Over 40 billion yuan was lifted in a single day! There will be a small peak next Monday when the ban will be lifted; ② Attention! These 7 stocks have been banned for a large amount and a large percentage of them “double listed.”
Hongsoft Technology: AI commercials are discussing the gradual expansion of “smart superdomain integration” product coverage models with multiple e-commerce platforms | Direct access to performance meetings
① In addition to the Ali 1688 platform, the commercial product “PhotoStudioAI” is also negotiating cooperation with various e-commerce platforms, and will gradually be launched according to the work progress of PhotoStudioAI and each platform. ② Revenue from the mobile phone business rebounded in 2023. Thanks to smart superdomain fusion technology products, it has received a good market response, and is currently expanding to mid-range and low-end models.
Science and Technology Innovation Board Evening News | Huaqiang Technology was banned from participating in military material engineering service procurement activities within 3 years, and Nanwang Technology plans to acquire 100% of Guangzhou Huineng's sh
① China and the US will hold the first meeting of the intergovernmental dialogue on artificial intelligence; ② Zhimingda will stop issuing convertible bonds to unspecified targets and withdraw application documents; ③ Xinzhi Software plans to raise no more than 300 million yuan in capital.
Strong inflow of foreign capital is another trend vane: Middle Eastern tycoons increase their presence in China, and multinational sovereign wealth funds continue to lay out A-shares
① The Abu Dhabi Investment Authority and the Kuwait Investment Authority held a large number of A-share listed companies in the first quarter; ② the Middle East Sovereign Fund also stepped up research on A-shares ③ Other overseas sovereign wealth funds are increasing their layout in the Chinese market.
Looking for the 3 billion market? Shengxiang Biological Water Test Rapid Drug Sensitivity Test Track
① “We still do it in the form of strategic investment rather than financial investment. Newly established companies are not included in the scope of the company's statements.” ② If Hunan Shengwei Sumin's subsequent business becomes more mature, it is not ruled out that Shengxiang Biotech will take more actions other than strategic investment.
Guoxin Securities's re-receipt warning letter concerns the use of capital raised by science and technology innovation board company Opt
① Xu Xueliang, director of Opt, once told the “Science and Technology Innovation Board Daily” reporter, “Mainly because the early plans between fund-raising projects were not clear, but the funds for the fund-raising projects were distributed normally to the project, and no fund-raising project funds were misappropriated.” ② Guoxin Securities also received 2 warning letters in April of this year, which involved various issues relating to the company's compliance and internal control. At the same time, the company's executive positions also recently completed a new round of changes.